Michael T. Nurmohamed
- Rheumatology top 0.02%
- Rheumatoid Arthritis Research and Therapies 246
- Systemic Lupus Erythematosus Research 124
- Spondyloarthritis Studies and Treatments 98
- Internal Medicine top 0.2%
- Venous Thromboembolism Diagnosis and Management 31
- Hematology top 0.2%
- Autoimmune and Inflammatory Disorders Research 74
- Immunology top 0.5%
- Biosimilars and Bioanalytical Methods 32
-
- Chronic Lymphocytic Leukemia Research 43
-
- Monoclonal and Polyclonal Antibodies Research 43
- Co-authors
- Ben A. C. DijkmansGertjan WolbinkWillem F. LemsAlexandre E. VoskuylIrene E. van der Horst‐BruinsmaYvo M. SmuldersMike J. PetersVokko P. van Halm
- Partner nations
- NetherlandsUnited StatesUnited Kingdom
In The Last Decade
Michael T. Nurmohamed
398 papers receiving 13.2k citations
Hit Papers
Peers
Comparison fields: 5 of 139
- Rheumatology 8.2k
- Internal Medicine 1.1k
- Hematology 2.2k
- Immunology 3.7k
- Cardiology and Cardiovascular Medicine 2.2k
Countries citing papers authored by Michael T. Nurmohamed
This map shows the geographic impact of Michael T. Nurmohamed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael T. Nurmohamed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael T. Nurmohamed more than expected).
Fields of papers citing papers by Michael T. Nurmohamed
This network shows the impact of papers produced by Michael T. Nurmohamed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael T. Nurmohamed. The network helps show where Michael T. Nurmohamed may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michael T. Nurmohamed, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 3 | |
| 5 | 2023 | 10 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 14 | |
| 8 | 2023 | 3 | |
| 9 | 2022 | 41 | |
| 10 | 2022 | 1 | |
| 11 | 2021 | 3 | |
| 12 | 2021 | 2 | |
| 13 | 2021 | 41 | |
| 14 | 2020 | 1 | |
| 15 | 2019 | 35 | |
| 16 | 2019 | 41 | |
| 17 | 2017 | 5 | |
| 18 | 2017 | 53 | |
| 19 | Disease modifying anti-rheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study | 2006 | 18 |
| 20 | DERMATAN SULFATE IN HEMODIALYSIS | 1992 | 1 |
About Michael T. Nurmohamed
Michael T. Nurmohamed is a scholar working on Rheumatology, Internal Medicine and Hematology, having authored 423 papers that have together received 13.6k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (246 papers), Systemic Lupus Erythematosus Research (124 papers), Spondyloarthritis Studies and Treatments (98 papers), Autoimmune and Inflammatory Disorders Research (74 papers), Chronic Lymphocytic Leukemia Research (43 papers), Monoclonal and Polyclonal Antibodies Research (43 papers), Biosimilars and Bioanalytical Methods (32 papers) and Venous Thromboembolism Diagnosis and Management (31 papers). The work is most often cited by research in Rheumatology (8.2k citations), Internal Medicine (1.1k citations) and Hematology (2.2k citations). Michael T. Nurmohamed has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Ben A. C. Dijkmans, Gertjan Wolbink, Willem F. Lems, Alexandre E. Voskuyl, Irene E. van der Horst‐Bruinsma, Yvo M. Smulders, Mike J. Peters, Vokko P. van Halm, Hennie G. Raterman and Maarten Boers. Their work appears in journals such as New England Journal of Medicine, The Lancet and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.